Malte Beringer

Malte Beringer

Auto-generated profile, based on publicly available information

Malte Beringer

Institute of Physical Biochemistry, University of Witten/Herdecke, 58448 Witten, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Cell
Verified
Journal Article
Closed access
UØUlf Ørom
Ulf Ørom
TDThomas Derrien
Thomas Derrien
MBMalte Beringer
Malte Beringer
KGKiranmai Gumireddy
Kiranmai Gumireddy
AGAlessandro Gardini
Alessandro Gardini
RSRamin Shiekhattar
Ramin Shiekhattar

17 February 2013 in Nature
Verified
Journal Article
Open access
PDF file
FLFan Lai
Fan Lai
UØUlf Ørom
Ulf Ørom
MCMatteo Cesaroni
Matteo Cesaroni
MBMalte Beringer
Malte Beringer
DTDylan J. Taatjes
Dylan J. Taatjes
RSRamin Shiekhattar
Ramin Shiekhattar
A class of long non-coding RNA (lncRNA) with enhancer-like activity is found to associate with the co-activator complex Mediator and promote its genomic association and enzymatic activity; together with Mediator, the lncRNAs also help to maintain the chromosomal architecture of active regulatory elements. Long non-coding RNAs (lncRNAs) can both repress and activate gene expression. Here, a class of lncRNAs with enhancer-like activity is found to associate with the translational co-activator complex Mediator. Termed ncRNA-activating (ncRNA-a), these molecules promote the genomic association and enzymatic activity of Mediator, and acting together with Mediator, they also help to maintain the chromosomal architecture of active regulatory elements. Importantly, Mediator complexes containing disease-linked mutant MED12 proteins fail to associate with ncRNA-a. The MED12 gene encodes a Mediator complex subunit, and MED12 mutations have been linked to FG syndrome, a rare genetic disorder with symptoms including intellectual disability. This work suggests that the loss of Mediator–ncRNA-a interactions might be a possible contributing factor in such developmental diseases. Recent advances in genomic research have revealed the existence of a large number of transcripts devoid of protein-coding potential in multiple organisms1,2,3,4,5,6,7,8. Although the functional role for long non-coding RNAs (lncRNAs) has been best defined in epigenetic phenomena such as X-chromosome inactivation and imprinting, different classes of lncRNAs may have varied biological functions8,9,10,11,12,13. We and others have identified a class of lncRNAs, termed ncRNA-activating (ncRNA-a), that function to activate their neighbouring genes using a cis-mediated mechanism5,14,15,16. To define the precise mode by which such enhancer-like RNAs function, we depleted factors with known roles in transcriptional activation and assessed their role in RNA-dependent activation. Here we report that depletion of the components of the co-activator complex, Mediator, specifically and potently diminished the ncRNA-induced activation of transcription in a heterologous reporter assay using human HEK293 cells. In vivo, Mediator is recruited to ncRNA-a target genes and regulates their expression. We show that ncRNA-a interact with Mediator to regulate its chromatin localization and kinase activity towards histone H3 serine 10. The Mediator complex harbouring disease-17,18 displays diminished ability to associate with activating ncRNAs. Chromosome conformation capture confirmed the presence of DNA looping between the ncRNA-a loci and its targets. Importantly, depletion of Mediator subunits or ncRNA-a reduced the chromatin looping between the two loci. Our results identify the human Mediator complex as the transducer of activating ncRNAs and highlight the importance of Mediator and activating ncRNA association in human disease.

12 May 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ASAnnette Sievers
Annette Sievers
MBMalte Beringer
Malte Beringer
MRMarina Rodnina
Marina Rodnina
RWRichard Wolfenden
Richard Wolfenden
To determine the effectiveness of the ribosome as a catalyst, we compared the rate of uncatalyzed peptide bond formation, by the reaction of the ethylene glycol ester of N -formylglycine with Tris(hydroxymethyl)aminomethane, with the rate of peptidyl transfer by the ribosome. Activation parameters were also determined for both reactions, from the temperature dependence of their second-order rate constants. In contrast with most protein enzymes, the enthalpy of activation is slightly less favorable on the ribosome than in solution. The 2 × 10 7 -fold rate enhancement produced by the ribosome is achieved entirely by lowering the entropy of activation. These results are consistent with the view that the ribosome enhances the rate of peptide bond formation mainly by positioning the substrates and/or water exclusion within the active site, rather than by conventional chemical catalysis.

1 November 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
IWIngo Wohlgemuth
Ingo Wohlgemuth
SBSibylle Brenner
Sibylle Brenner
MBMalte Beringer
Malte Beringer
MRMarina Rodnina
Marina Rodnina
The ribosome catalyzes peptide bond formation between peptidyl-tRNA in the P site and aminoacyl-tRNA in the A site. Here, we show that the nature of the C-terminal amino acid residue in the P-site peptidyl-tRNA strongly affects the rate of peptidyl transfer. Depending on the C-terminal amino acid of the peptidyl-tRNA, the rate of reaction with the small A-site substrate puromycin varied between 100 and 0.14 s–1, regardless of the tRNA identity. The reactivity decreased in the order Lys = Arg > Ala > Ser > Phe = Val > Asp ≫ Pro, with Pro being by far the slowest. However, when Phe-tRNAPhe was used as A-site substrate, the rate of peptide bond formation with any peptidyl-tRNA was ∼7 s–1, which corresponds to the rate of binding of Phe-tRNAPhe to the A site (accommodation). Because accommodation is rate-limiting for peptide bond formation, the reaction rate is uniform for all peptidyl-tRNAs, regardless of the variations of the intrinsic chemical reactivities. On the other hand, the 50-fold increase in the reaction rate for peptidyl-tRNA ending with Pro suggests that full-length aminoacyl-tRNA in the A site greatly accelerates peptide bond formation.

1 May 2007 in Molecular Cell
Verified
Journal Article
Closed access
MBMalte Beringer
Malte Beringer
MRMarina Rodnina
Marina Rodnina

1 November 2016 in Molecular Cell
Verified
Journal Article
Closed access
MBMalte Beringer
Malte Beringer
PPPaola Pisano
Paola Pisano
VCValerio Di Carlo
Valerio Di Carlo
EBEnrique Blanco
Enrique Blanco
PCPaul Chammas
Paul Chammas
Luciano Di CroceLuciano Di Croce
Luciano Di Croce